Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: Liver Transpl. 2012 Oct 10;18(11):1302–1309. doi: 10.1002/lt.23537

Table 4.

Reasons for exception point applications

Reason for exception application Number of applications, N (%) Applications approved, N (%)* Asked for points to allow patient to receive organ under Share 15 policy Number individual applicants Applicants transplanted, N (%)
Encephalopathy 72 (15.9) 58 (80.6) 29 (40.3) 43 (14.3) 26 (61.9)
Hepatocellular carcinoma 70 (15.5) 56 (80.0) 19 (27.1) 63 (20.9) 52 (82.5)
Refractory ascites 50 (11.1) 37 (74.0) 19 (38.0) 39 (13.0) 21 (55.3)
Recurrent cholangitis 43 (9.5) 34 (79.1) 8 (18.6) 25 (8.3) 16 (64.0)
Pruritus 36 (8.0) 30 (83.3) 18 (50.0) 16 (5.3) 8 (57.1)
Symptomatic polycystic liver disease 35 (7.7) 32 (91.4) 1 (2.9) 19 (6.3) 14 (77.8)
Other liver tumors 26 (5.8) 23 (88.5) 10 (38.5) 21 (7.0) 12 (57.1)
Other 29 (6.4) 21 (72.4) 11 (37.9) 17 (5.7) 13 (76.5)
Refractory hydrothorax 21 (4.7) 18 (85.7) 7 (33.3) 12 (4.0) 7 (58.3)
Recurrent variceal bleed 23 (5.1) 17 (73.9) 6 (26.1) 17 (5.7) 12 (70.6)
Other non-variceal GI bleeding 22 (4.9) 19 (86.4) 3 (13.6) 13 (4.3) 7 (53.9)
PV or SMV thrombosis 15 (3.3) 11 (73.3) 7 (46.7) 8 (2.7) 3 (37.5)
Spontaneous bacterial peritonitis 6 (1.3) 6 (100.0) 1 (16.7) 5 (1.7) 3 (60.0)
Portopulmonary HTN or HPS 4 (0.9) 4 (100.0) 1 (25.0) 3 (1.0) 3 (100.0)
*

P=0.61

Either asked for 15 points to specifically be eligible, to be able to get local, regional, or donation after cardiac deathor extended-criteria donor organs. P=0.001; overall 148 (31.0%) of applications made specific mention of asking for 15 points to receive a score high enough to receive anorgan. 85.7% vs. 78.9% (P=0.09) applications accepted when made specific mention (or not) of wanting exception points to receive organ

P=0.11